Skip to main content
. Author manuscript; available in PMC: 2011 Apr 15.
Published in final edited form as: J Infect Dis. 2010 Apr 15;201(8):1225–1231. doi: 10.1086/651377

Table 1.

Percentage of reserpine inhibited ethambutol resistant subpopulation by dosing schedule

Regimen Daily therapy (%) Once a week (%)
Control (AUC0–168/MIC=0 ) 0.5 -
Regimen 1 (AUC0–168/MIC= 2.99) 28.7 60.5
Regimen 2 (AUC0–168/MIC=8.63 ) 8.0 88.7
Regimen 3 (AUC0–168/MIC=17.26 ) 74.8
Regimen 4 (AUC0–168/MIC= 33.19) 7.1